nach oben

Neurocritical Care

Erschienen in:

19.12.2016 | Review Article

Zika Virus Disease for the Neurointensivist

verfasst von: Daniel M. Pastula, Julia C. Durrant, Daniel E. Smith, J. David Beckham, Kenneth L. Tyler

Erschienen in: Neurocritical Care | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Zika virus (ZIKV) is a mosquito-borne and sexually transmitted flavivirus currently spreading throughout the Pacific and Western Hemisphere. ZIKV infection is often either asymptomatic or causes a self-limiting illness with symptoms such as rash, fever, myalgia, arthralgia, headache, or conjunctivitis. Rarely, ZIKV infection has been associated with conditions such as severe thrombocytopenia, microcephaly and other developmental abnormalities, acute polyneuropathy/Guillain–Barré syndrome, myelitis, meningoencephalitis, transient encephalopathy, provoked seizures, and various ophthalmologic conditions. Optimal treatment of these ZIKV-associated conditions is currently unclear and is largely guided by expert opinion or case reports/series. Further studies are needed to establish best treatment practices. This review concentrates on caring by neurointensivists for the patient affected with Zika virus-expected to flare up again in the summer.

CDC arbocat website. https://wwwn.cdc.gov/arbocat/. Accessed 18 Sept 2016.

Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46(5):509–20.CrossRefPubMed

Simpson DI. Zika virus infection in man. Trans R Soc Trop Med Hyg. 1964;58:335–8.CrossRefPubMed

Moore DL, Causey OR, Carey DE, et al. Arthropod-borne viral infections of man in Nigeria, 1964–1970. Ann Trop Med Parasitol. 1975;69:49–64.CrossRefPubMed

Fagbami AH. Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg. 1979;83:213–9.CrossRefPubMedPubMedCentral

Filipe AR, Martins CM, Rocha H. Laboratory infection with Zika virus after vaccination against yellow fever. Arch Gesamte Virusforsch. 1973;43:315–9.CrossRefPubMed

Olson JG, Ksiazek TG, Suhandiman T. Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg. 1981;75:389–93.CrossRefPubMed

Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Islands, federated states of Micronesia. N Engl J Med. 2009;360(24):2536–43.CrossRefPubMed

Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 2014;20:595–6.CrossRef

10.

Zanluca C, de Melo VCA, Mosimann ALP, dos Santos GIV, dos Santos CND, Luz K. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz. 2015;110:569–72.CrossRefPubMedPubMedCentral

11.

PAHO Zika cumulative cases website. http://www.paho.org/hq/index.php?option=com_content&view=article&id=12390&Itemid=42090&lang=en. Accessed 18 Sept 2016.

12.

CDC maps of Zika in the United States website. https://www.cdc.gov/zika/intheus/maps-zika-us.html. Accessed 18 Sept 2016.

13.

CDC Zika virus transmission and risks website. https://www.cdc.gov/zika/transmission/index.html. Accessed 18 Sept 2016.

14.

Brooks JT, Friedman A, Kachur RE, LaFlam M, Peters PJ, Jamieson DJ. Update: interim guidance for prevention of sexual transmission of Zika virus—United States, July 2016. MMWR Morb Mortal Wkly Rep. 2016;65:745–7.CrossRefPubMed

15.

Barjas-Castro ML, Angerami RN, Cunha MS, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion. 2016;56(7):1684–8.CrossRefPubMed

16.

FDA advises testing for Zika virus in all donated blood and blood components in the US press release. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm518218.htm. Accessed 18 Sept 2016.

17.

Driggers RW, Ho CY, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med. 2016;374:2142–51.CrossRefPubMed

18.

CDC Zika virus clinical evaluation and disease website. https://www.cdc.gov/zika/hc-providers/preparing-for-zika/clinicalevaluationdisease.html. Accessed 18 Sept 2016.

19.

Karimi O, Goorhuis A, Schinkel J, et al. Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection. Lancet. 2016;387:939–40.CrossRefPubMed

20.

Sarmiento-Ospina A, Vásquez-Serna H, Jimenez-Canizales CE, Villamil-Gómez WE, Rodriguez-Morales AJ. Zika virus associated deaths in Colombia. Lancet Infect Dis. 2016;16:523–4.CrossRefPubMed

21.

Sharp TM, Muñoz-Jordán J, Perez-Padilla J, et al. Zika virus infection associated with severe thrombocytopenia. Clin Infect Dis. 2016;63:1198–201.PubMed

22.

Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects–reviewing the evidence for causality. N Engl J Med. 2016;374(20):1981–7.CrossRefPubMed

23.

Russell K, Oliver SE, Lewis L, et al. Update: interim guidance for the evaluation and management of infants with possible congenital Zika virus infection—United States, August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:870–8.CrossRefPubMed

24.

van der Linden V, Filho EL, Lins OG, et al. Congenital Zika syndrome with arthrogryposis: retrospective case series study. BMJ. 2016;9(354):i3899.CrossRef

25.

Leal MC, Muniz LF, Ferreira TS, et al. Hearing loss in infants with microcephaly and evidence of congenital Zika virus infection—Brazil, November 2015–May 2016. MMWR Morb Mortal Wkly Rep. 2016;65(34):917–9.CrossRefPubMed

26.

Silva AAM, Ganz JSS, Sousa PS, et al. Early growth and neurologic outcomes of infants with probable congenital Zika virus syndrome. Emerg Infect Dis. 2016;22:1953–56.CrossRefPubMedPubMedCentral

27.

Hazin AN, Poretti A, Turchi Martelli CM, et al. Computed tomographic findings in microcephaly associated with Zika virus. N Engl J Med. 2016;374:2193–5.CrossRefPubMed

28.

Soares de Oliveira-Szejnfeld P, Levine D, Melo AS, et al. Congenital brain abnormalities and Zika virus: what the radiologist can expect to see prenatally and postnatally. Radiology. 2016;281:203–18.CrossRefPubMed

29.

Carod-Artal FJ, Wichmann O, Farrar J, Gascon J. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12(9):906–19.CrossRefPubMed

30.

Lebrun G, Chadda K, Reboux AH, Martinet O, Gauzere BA. Guillain–Barre syndrome after chikungunya infection. Emerg Infect Dis. 2009;15(3):495–6.CrossRefPubMedPubMedCentral

31.

Wielanek AC, Monredon JD, Amrani ME, Roger JC, Serveaux JP. Guillain–Barre syndrome complicating a chikungunya virus infection. Neurology. 2007;69(22):2105–7.CrossRefPubMed

32.

Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain–Barré syndrome—case report, French Polynesia, December 2013. Euro Surveill. 2014;19(9):20720.CrossRefPubMed

33.

Cao-Lormeau VM, Blake A, Mons S, et al. Guillain–Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case–control study. Lancet. 2016;387(10027):1531–9.CrossRefPubMed

34.

Roze B, Najioullah F, Ferge J, et al. Zika virus detection in urine from patients with Guillain Barre syndrome on Martinique, January 2016. Euro Surveill. 2016;21(9). doi:10.2807/1560-7917.ES.2016.21.9.30154.

35.

Brasil P, Sequeira PC, Freitas AD, et al. Guillain–Barré syndrome associated with Zika virus infection. Lancet. 2016;387(10026):1482.CrossRefPubMed

36.

Kassavetis P, Joseph JB, Francois R, Perloff MD, Berkowitz AL. Zika virus-associated Guillain–Barre syndrome variant in Haiti. Neurology. 2016;87(3):336–7.CrossRefPubMed

37.

Siu R, Bukhari W, Todd A, Gunn W, Huang QS, Timmings P. Acute Zika infection with concurrent onset of Guillain–Barré syndrome. Neurology. 2016;87:1623–24.CrossRefPubMed

38.

Arias A, Torres-Tobar L, Hernández G, et al. Guillain–Barré syndrome in patients with a recent history of Zika in Cúcuta, Colombia: a descriptive case series of 19 patients from December 2015 to March 2016. J Crit Care. 2016;37:19–23.CrossRefPubMed

39.

Styczynski AMJ, Krow-Lucal E, Percio J, et al. Guillain Barré syndrome outbreak—Bahia State, Brazil. In: CDC 65th EIS conference 2016.

40.

Dirlikov E, Major CG, Mayshack M, et al. Guillain–Barré syndrome during ongoing Zika virus transmission—Puerto Rico, January 1–July 31, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(34):910–4.CrossRefPubMed

41.

Mécharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection. Lancet. 2016;387(10026):1481.CrossRefPubMed

42.

Carteaux G, Maquart M, Bedet A, et al. Zika virus associated with meningoencephalitis. N Engl J Med. 2016;374(16):1595–6.CrossRefPubMed

43.

Nicastri E, Castilletti C, Balestra P, Galgani S, Ippolito G. Zika virus infection in the central nervous system and female genital tract. Emerg Infect Dis. 2016;22:2228–30.CrossRefPubMedPubMedCentral

44.

Soares CN, Brasil P, Carrera RM, et al. Fatal encephalitis associated with Zika virus infection in an adult. J Clin Virol. 2016;83:63–5.CrossRefPubMed

45.

Rozé B, Najioullah F, Signate A, et al. Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016. Euro Surveill. 2016;21(16). doi: 10.2807/1560-7917.ES.2016.21.16.30205.

46.

Furtado JM, Esposito DL, Klein TM, Teixeira-Pinto T, da Fonseca BA. Uveitis associated with Zika virus infection. N Engl J Med. 2016;375(4):394–6.CrossRefPubMed

47.

Parke DW, Almeida DR, Albini TA, et al. Serologically confirmed Zika-related unilateral acute maculopathy in an adult. Ophthalmology. 2016;123:2432–33.CrossRefPubMed

48.

CDC testing for Zika virus website. http://www.cdc.gov/zika/hc-providers/testing-for-zikavirus.html. Accessed 18 Sept 2016.

49.

Rabe IB, Staples JE, Villanueva J, et al. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep. 2016;65(21):543–6.CrossRefPubMed

50.

CDC Zika virus treatment website. https://www.cdc.gov/zika/symptoms/treatment.html. Accessed 18 Sept 2016.

51.

Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;61(6):736–40.CrossRefPubMed

52.

Hughes RA, Wijdicks EF, Benson E, et al. Supportive care for patients with Guillain–Barré syndrome. Arch Neurol. 2005;62:1194.CrossRefPubMed

53.

Yuki N, Hartung HP. Guillain–Barré syndrome. N Engl J Med. 2012;366(24):2294–304.CrossRefPubMed

54.

Thiery G, Valentino R, Meddhaoui H. Zika virus-associated Guillain–Barre syndrome: a warning for critical care physicians. Intensive Care Med. 2016;42(9):1485–6.CrossRefPubMed

55.

Raslan A, Bhardwaj A. Medical management of cerebral edema. Neurosurg Focus. 2007;22(5):E12.CrossRefPubMed

56.

Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.CrossRefPubMed

57.

Morrison C. DNA vaccines against Zika virus speed into clinical trials. Nat Rev Drug Discov. 2016;15(8):521–2.CrossRefPubMed

58.

CDC Zika virus prevention website. https://www.cdc.gov/zika/prevention/index.html. Accessed 18 Sept 2016.

Titel: Zika Virus Disease for the Neurointensivist
verfasst von: Daniel M. Pastula
Julia C. Durrant
Daniel E. Smith
J. David Beckham
Kenneth L. Tyler
Publikationsdatum: 19.12.2016
Verlag: Springer US
Erschienen in: Neurocritical Care / Ausgabe 3/2017
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-016-0333-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zika Virus Disease for the Neurointensivist

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

An NIHSS of 0 and a Very Disabling Stroke

Isolated Brain Trauma in Cats Triggers Rapid Onset of Hypovolemia

Bedside Ultrasound After Decompressive Craniectomy: A New Standard?

Delayed Deterioration of EEG Background Rhythm Post-cardiac Arrest

Autophagy Biomarkers Beclin 1 and p62 are Increased in Cerebrospinal Fluid after Traumatic Brain Injury

Biomarkers of Glycocalyx Injury are Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Case Series Supporting a New Hypothesis

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie